Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
0.7%
operating margin TTM
3.09%
revenue TTM
571.75 Million
revenue per share TTM
14.54$
valuation ratios | |
|---|---|
| pe ratio | 197.55 |
| peg ratio | -3.49 |
| price to book ratio | 1.49 |
| price to sales ratio | 1.29 |
| enterprise value multiple | 5.76 |
| price fair value | 1.49 |
profitability ratios | |
|---|---|
| gross profit margin | 79.34% |
| operating profit margin | 3.09% |
| pretax profit margin | 1.79% |
| net profit margin | 0.7% |
| return on assets | 0.43% |
| return on equity | 0.73% |
| return on capital employed | 2.06% |
liquidity ratios | |
|---|---|
| current ratio | 4.73 |
| quick ratio | 3.35 |
| cash ratio | 1.33 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 361.43 |
| operating cycle | 423.83 |
| days of payables outstanding | 33.68 |
| cash conversion cycle | 390.15 |
| receivables turnover | 5.85 |
| payables turnover | 10.84 |
| inventory turnover | 1.01 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.34 |
| debt equity ratio | 0.63 |
| long term debt to capitalization | 0.36 |
| total debt to capitalization | 0.39 |
| interest coverage | 1.52 |
| cash flow to debt ratio | 0.35 |
cash flow ratios | |
|---|---|
| free cash flow per share | 3.28 |
| cash per share | 5.00 |
| operating cash flow per share | 3.51 |
| free cash flow operating cash flow ratio | 0.93 |
| cash flow coverage ratios | 0.35 |
| short term coverage ratios | 14.49 |
| capital expenditure coverage ratio | 14.96 |
Frequently Asked Questions
When was the last time Pacira BioSciences, Inc. (NASDAQ:PCRX) reported earnings?
Pacira BioSciences, Inc. (PCRX) published its most recent earnings results on 30-04-2026.
What is Pacira BioSciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Pacira BioSciences, Inc. (NASDAQ:PCRX)'s trailing twelve months ROE is 0.73%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Pacira BioSciences, Inc. (PCRX) currently has a ROA of 0.43%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PCRX's net profit margin stand at?
PCRX reported a profit margin of 0.7% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PCRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.73 in the most recent quarter. The quick ratio stood at 3.35, with a Debt/Eq ratio of 0.63.